Expertise in
1
conditions

Dr. Deborah A. Burke

Tampa, FL
Expertise in
1
conditions
Specialties:Neurology
Accepting New Patients
Expertise in
1
conditions
OverviewInsuranceLocationsClinical Research

Overview

Deborah Burke is a Neurologist in Tampa, Florida. Dr. Burke is highly rated in 1 condition, according to our data. Her top areas of expertise are Parkinson's Disease, Lewy Body Dementia (LBD), Cerebellar Degeneration, and Essential Tremor. Dr. Burke is currently accepting new patients.

Her clinical research consists of participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in FL
Languages Spoken
English
Gender
Female

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Blue Cross Blue Shield
  •  Oscar
  •  Humana

Locations

5 Tampa General Cir, Suite 410, Tampa, FL 33606
813-866-1600

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 09, 2024
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Multicenter, Prospective, Longitudinal, Digital Assessment Study of Disease Progression in Subjects with Early, Untreated Parkinson Disease
A Multicenter, Prospective, Longitudinal, Digital Assessment Study of Disease Progression in Subjects with Early, Untreated Parkinson Disease
Enrollment Status: Completed
Publish Date: October 08, 2024
A Multicenter, Open Label Study to Evaluate Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Dementia.
A Multicenter, Open Label Study to Evaluate Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Dementia.
Enrollment Status: Withdrawn
Publish Date: March 01, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 1
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 2
An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With Attention-Deficit/Hyperactivity Disorder
An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With Attention-Deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: February 13, 2024
Intervention Type: Drug
Study Drug: SPN-812
Study Phase: Phase 3
The Parkinson's Progression Markers Initiative (PPMI)
The Parkinson's Progression Markers Initiative (PPMI)
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: DaTscan
Study Phase: Phase 2
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Flexible-Dose Study of the Efficacy and Safety of SPN-812 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Flexible-Dose Study of the Efficacy and Safety of SPN-812 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Enrollment Status: Completed
Publish Date: July 12, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2a Combined Open-Label and Double-Blind, Placebo-Controlled Crossover Study Assessing the Effectiveness, Safety, and Tolerability of Oral Fasudil in Subjects With Dementia and Wandering Behaviors of Elopement and/or Getting Lost
A Phase 2a Combined Open-Label and Double-Blind, Placebo-Controlled Crossover Study Assessing the Effectiveness, Safety, and Tolerability of Oral Fasudil in Subjects With Dementia and Wandering Behaviors of Elopement and/or Getting Lost
Enrollment Status: Completed
Publish Date: July 11, 2022
Intervention Type: Drug
Study Drug: Oral Fasudil
Study Phase: Phase 2
View 8 Less Clinical Trials
Similar Doctors
Expertise in
16
conditions
Dr. Theresa A. Zesiewicz
Neurology
Expertise in
16
conditions
Dr. Theresa A. Zesiewicz
Neurology

University Medical Service Association Inc

4001 E Fletcher Ave, 
Tampa, FL 
 (9.4 mi)
813-866-1600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Theresa Zesiewicz is a Neurologist in Tampa, Florida. Dr. Zesiewicz is highly rated in 16 conditions, according to our data. Her top areas of expertise are Friedreich Ataxia, Spinocerebellar Ataxia, Drug Induced Dyskinesia, Hereditary Ataxia, and Deep Brain Stimulation. Dr. Zesiewicz is currently accepting new patients.

Expertise in
12
conditions
Dr. Maxim V. Mokin
Neurology
Expertise in
12
conditions
Dr. Maxim V. Mokin
Neurology

University Medical Service Association Inc

2 Tampa General Cir, 
Tampa, FL 
 (0.1 mi)
813-821-8038
Languages Spoken:
English, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Maxim Mokin is a Neurologist in Tampa, Florida. Dr. Mokin is highly rated in 12 conditions, according to our data. His top areas of expertise are Stroke, Brain Aneurysm, Apoplexy, Thrombectomy, and Stent Placement. Dr. Mokin is currently accepting new patients.

Expertise in
11
conditions
Dr. Robert A. Hauser
Neurology
Expertise in
11
conditions
Dr. Robert A. Hauser
Neurology

University Medical Service Association Inc

13330 Usf Laurel Dr, 
Tampa, FL 
 (9.3 mi)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Hauser is a Neurologist in Tampa, Florida. Dr. Hauser is highly rated in 11 conditions, according to our data. His top areas of expertise are Parkinson's Disease, Tardive Dyskinesia, Drug Induced Dyskinesia, and Neurotoxicity Syndromes. Dr. Hauser is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile